Company Profile (AI Text)
Name: Pace Diagnostics
Canonical URL: https://wefunder.com/pace.diagnostics
Updated at: 2026-06-02T23:54:48Z

Tagline: Revolutionary point-of-care, affordable early detection Lung cancer and Tuberculosis diagnostics
Elevator pitch: Pace Diagnostics is an emerging biotechnology company focused on the research, development, licensing, manufacturing and marketing of cutting-edge human diagnostics. We are developing novel, first to market, low cost, accurate, early detection lung cancer and tuberculosis point of care diagnostics, non-lab dependent with result in less than 30 minutes.

Key claims:
- Total raised on Wefunder: 127079 | citation: https://wefunder.com/pace.diagnostics#claim-total-raised
- Total investors: 111 | citation: https://wefunder.com/pace.diagnostics#claim-total-investors

Verified facts:
- Total raised on Wefunder: 127079 | observed_at: 2026-06-02T23:54:48Z | expires_at: 2026-06-03T23:54:48Z
- Total investors: 111 | observed_at: 2026-06-02T23:54:48Z | expires_at: 2026-06-03T23:54:48Z

Computed metrics:
- total_amount_raised: 127079
- total_investors: 111
- team_size: 5
- featured_investor_count: 0
- faq_count: 4
- recent_post_count: 0

Quick facts:
- Raised $2.5 million in seed investment; Won > $6 million in grants from US DoD, NIH, and NSF | citation: https://wefunder.com/pace.diagnostics#claim-fact-1
- Huge markets and financial opportunities: 3.1 billion USD tuberculosis & 20 billion USD lung cancer diagnostics in 2022 | citation: https://wefunder.com/pace.diagnostics#claim-fact-2
- Our products - low cost, accurate, non-invasive, non-lab dependent lung cancer & tuberculosis tests | citation: https://wefunder.com/pace.diagnostics#claim-fact-3
- Our CE Mark is targeted for 2023, allowing product distribution in EU countries; clear path to FDA clinical trials | citation: https://wefunder.com/pace.diagnostics#claim-fact-4
- We have a portfolio of proprietary material, filed patents and licensed IPs | citation: https://wefunder.com/pace.diagnostics#claim-fact-5
- Each year: 10 million new TB infections & 2 million deaths; 2.1 million new Lung Cancer cases & 2 million new deaths | citation: https://wefunder.com/pace.diagnostics#claim-fact-6
- Our TB test is specifically developed to meet all WHO requirements for performance, cost and use | citation: https://wefunder.com/pace.diagnostics#claim-fact-7
- British Biocell International (BBI) is our manufacturing partner | citation: https://wefunder.com/pace.diagnostics#claim-fact-8

FAQ:
- Q: Hi. Do you have links to any peer reviewed studies from your years of development? I can not find anything either under the company name or any of the cofounders.
  A: Hello Liam, Thank you for visiting our company website and reviewing our Wefunder fundraising project. Pace Diagnostics and our predecessor have conducted several studies and generated multiple reports to US DoD (Department of Defense), US NIH (National Institutes of Health), and US NSF (National Science Foundation). Because the recipients of our reports and results of our studies are US federal government agencies, they are not fully accessible to the general public. However, we can provide ...
- Q: Hi, thanks for presenting the opportunity to us. Have a few questions I would like your views on if possible. 1) Could you share some of the scientific work and the marker you are using? 2) As you say to be filing for CE in 2022, could you comment on test accuracy (sensitivity...
  A: Hello Marlin, Thank you for taking time to visit our Wefunder equity fundraising campaign page and are interested on our products. We have reviewed your questions with our legal and management teams. Here are our responses to your questions: Question 1) we can’t disclose the details of our scientific works and type of markers because they are part of our IPs (Intellectual property’s). However, once we have our EU CE Mark granted and the US FDA PMA application filed, we can release some of the...
- Q: HI, this is a very impressive and compelling presentation that made the science easy to understand. Your team is excellent and your Lead Investor did a great job of describing her excitement about what you are doing. I have two questions: First, I know you cannot say too much ...
  A: Hello Alan, Thank you for taking time to review our products and for reaching out to ask these great questions. We will have to get into significant technical details to answer your questions. We will try to disclose some of the technical information without violating our IP disclosures. (1) Our technology innovations center on Tuberculosis-specific, pathogenesis-linked membrane-bound or membrane-associated protein antigens for the TB diagnostics patents. Membrane proteins are a challenging f...
- Q: We want to know what you see your valuation will look like in 3 years also the income and balance statements Not to say much, I think we are very much interested in this project but then we are not opting for the crowdfunding route. We were wondering if you have provisions to ...
  A: Hi Mr. Young, While we appreciate your interest in Pace Diagnostics, and our initiative to save lives through early detection, we are not considering alternative forms of investment at this time. Please feel free to reach out at a later date. Thank you again for your time and consideration. Regards, Lorne J. Mattner Chief Operating Officer Pace Diagnostics